We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

76 hedge funds and large institutions have $284M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

83% more capital invested

Capital invested by funds: $155M → $284M (+$129M)

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

9% more funds holding

Funds holding: 70 → 76 (+6)

Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.99%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
20
Increased
27
Reduced
16
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.88M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.58M
3
BFA
BlackRock Fund Advisors
California
+$3.72M
4
DCM
Driehaus Capital Management
Illinois
+$3.34M
5
CS
Candriam SCA
Luxembourg
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.55M
2
BI
BVF Inc
California
-$4.33M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.69M
4
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$2.4M
5
HLA
Hamilton Lane Advisors
Pennsylvania
-$1.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
QSS
51
Quantitative Systematic Strategies
Florida
$306K +$234K +17,019 New
SIM
52
Spark Investment Management
New York
$300K +$228K +16,600 New
Morgan Stanley
53
Morgan Stanley
New York
$279K +$89.5K +6,507 +73%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$231K +$25.5K +1,855 +17%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$219K – – –
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$191K +$127K +9,253 +722%
PPA
57
Parametric Portfolio Associates
Washington
$191K +$145K +10,550 New
BCM
58
Bridgeway Capital Management
Texas
$183K – – –
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$156K +$119K +8,620 +41,048%
AIG
60
American International Group
New York
$141K -$193 -14 -0.2%
Wells Fargo
61
Wells Fargo
California
$127K +$96.1K +6,982 +11,637%
Citigroup
62
Citigroup
New York
$122K +$92.1K +6,692 +11,153%
Deutsche Bank
63
Deutsche Bank
Germany
$112K -$5.26K -382 -6%
BA
64
BlackRock Advisors
Delaware
$105K -$26.2K -1,904 -25%
Bank of America
65
Bank of America
North Carolina
$79K +$58.9K +4,277 +3,625%
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$47.4K -$6.61K -480 -15%
PAM
67
Panagora Asset Management
Massachusetts
$44K +$33.1K +2,409 New
Axa
68
Axa
France
$43K -$12K -869 -27%
CG
69
Colony Group
Massachusetts
$39K – – –
TC
70
Travelers Companies
Minnesota
$22K -$41.3K -2,999 -72%
UBS Group
71
UBS Group
Switzerland
$18K +$13.8K +1,000 New
TRCT
72
Tower Research Capital (TRC)
New York
$14K +$10.6K +772 New
GWM
73
Gupta Wealth Management
California
$10K +$5.3K +385 +216%
Barclays
74
Barclays
United Kingdom
$10K +$6.38K +464 +663%
BlackRock
75
BlackRock
New York
$4K – – –
1 2
3
4

VTAE Hedge Fund Activity: Q4 2015 in Review

76 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2015, worth a combined $284M — up 83% from $155M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VTAE positions and 14 closed out — a net gain of 6 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $9.88M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.55M sold.

  • 76 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2015, up from 70 in Q3 2015.
  • Funds reported $284M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2015, up 83% quarter-over-quarter.
  • 20 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2015 and 14 closed out, a net change of +6 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q4 2015 was Adage Capital Partners, an estimated $9.88M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2015 was Point72 Asset Management, an estimated $6.55M sold.

Based on aggregated 13F filings for Q4 2015.